Bayesian modelling for COVID-19 seroprevalence studies

Adjusting COVID-19 seroprevalence survey results to account for test sensitivity and specificity

SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard

COVID-19: Estimating the historical time series of infections

Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA

Bayesian modelling for COVID-19 seroprevalence studies

Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis - ScienceDirect

Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan

Bayesian modelling for COVID-19 seroprevalence studies

Full article: Bayesian network analysis of Covid-19 data reveals higher infection prevalence rates and lower fatality rates than widely reported

Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England

Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies, BMC Infectious Diseases

Resurgence of SARS-CoV-2: Detection by community viral surveillance

Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys